Thus, many sporadic ovarian carcinomas have reduction of BRCA1 protein, mutations in p53, and better overall survival, mimicking the phenotype of hereditary BRCA1-associated ovarian carcinoma. This evidence concerns the gene TP53 and ovarian carcinoma.